SCHEMBL231375

SCHEMBL231375

CCN(CC)C(=O)c1ccc(C(c2cccc(O)c2)N2CCN(Cc3ccccc3)CC2)cc1

nearest known ligand 0.81

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
OPRD1 P41143 13/20 0.67
OPRM1 P35372 3/20 0.64
OPRK1 P41145 2/20 0.64
KCNH2 Q12809 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15764535 1.00 OPRD1 (0.67) OPRD1OPRM1OPRK1KCNH2
SCHEMBL4825406 0.90 OPRD1 (0.67) OPRD1OPRM1OPRK1KCNH2
SCHEMBL9925784 0.90 OPRD1 (0.67) OPRD1OPRM1OPRK1KCNH2
SCHEMBL12569760 0.89 OPRD1 (0.66) OPRD1OPRM1OPRK1KCNH2
SCHEMBL14108184 0.89 OPRD1 (0.66) OPRD1OPRM1OPRK1KCNH2
SCHEMBL84143 0.89 OPRD1 (0.66) OPRD1OPRM1OPRK1KCNH2
SCHEMBL4825427 0.89 OPRD1 (0.65) OPRD1OPRM1OPRK1KCNH2
SCHEMBL13771717 0.88 OPRD1 (0.66) OPRD1OPRM1OPRK1KCNH2
SCHEMBL6242273 0.88 OPRD1 (0.57) OPRD1OPRM1OPRK1KCNH2
SCHEMBL17283183 0.88 OPRD1 (0.60) OPRD1OPRM1OPRK1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120004242-A1 Oligomer-Diarylpiperazine Conjugates NEKTAR THERAPEUTICS (US) 2012-01-05 US claimed
JP-2011510078-A 2011-03-31 JP claimed
EP-2249872-A1 OLIGOMER-DIARYLPIPERAZINE CONJUGATES Nektar Therapeutics (US) 2010-11-17 EP claimed
WO-2009094209-A1 OLIGOMER-DIARYLPIPERAZINE CONJUGATES NEKTAR THERAPEUTICS AL, CORPORATION (US) 2009-07-30 WO claimed
EP-2249872-B1 OLIGOMER-DIARYLPIPERAZINE CONJUGATES NEKTAR THERAPEUTICS (US) 2017-03-22 EP disclosed
EP-2249872-B1 OLIGOMER-DIARYLPIPERAZINE CONJUGATES NEKTAR THERAPEUTICS (US) 2017-03-22 EP disclosed
US-9314463-B2 Oligomer-diarylpiperazine conjugates NEKTAR THERAPEUTICS (US) 2016-04-19 US disclosed
US-9314463-B2 Oligomer-diarylpiperazine conjugates NEKTAR THERAPEUTICS (US) 2016-04-19 US disclosed
US-20150335640-A1 OLIGOMER-DIARYLPIPERAZINE CONJUGATES NEKTAR THERAPEUTICS 2015-11-26 US disclosed
US-20150335640-A1 OLIGOMER-DIARYLPIPERAZINE CONJUGATES NEKTAR THERAPEUTICS 2015-11-26 US disclosed
US-9061026-B2 Oligomer-diarylpiperazine conjugates NEKTAR THERAPEUTICS (US) 2015-06-23 US disclosed
US-9061026-B2 Oligomer-diarylpiperazine conjugates NEKTAR THERAPEUTICS (US) 2015-06-23 US disclosed
US-20140155412-A1 OLIGOMER-DIARYLPIPERAZINE CONJUGATES NEKTAR THERAPEUTICS (US) 2014-06-05 US disclosed
US-20140155412-A1 OLIGOMER-DIARYLPIPERAZINE CONJUGATES NEKTAR THERAPEUTICS (US) 2014-06-05 US disclosed
US-20120004242-A1 Oligomer-Diarylpiperazine Conjugates NEKTAR THERAPEUTICS (US) 2012-01-05 US disclosed
US-20120004242-A1 Oligomer-Diarylpiperazine Conjugates NEKTAR THERAPEUTICS (US) 2012-01-05 US disclosed
EP-2249872-A1 OLIGOMER-DIARYLPIPERAZINE CONJUGATES Nektar Therapeutics (US) 2010-11-17 EP disclosed
WO-2009094209-A1 OLIGOMER-DIARYLPIPERAZINE CONJUGATES NEKTAR THERAPEUTICS AL, CORPORATION (US) 2009-07-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140155412-A1 OLIGOMER-DIARYLPIPERAZINE CONJUGATES BIRC5, MTX2, IAPP OPRD1 2294/4885OPRM1 574/4885OPRK1 1249/4885
US-20120004242-A1 Oligomer-Diarylpiperazine Conjugates BIRC5, MTX2, IAPP OPRD1 2294/4885OPRM1 574/4885OPRK1 1249/4885
US-20150335640-A1 OLIGOMER-DIARYLPIPERAZINE CONJUGATES BIRC5, MTX2, IAPP OPRD1 2294/4885OPRM1 574/4885OPRK1 1249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.